Table 2.
Univariable analysis of factors associated with DAIR failure.
| Categorical variables | ||||
|---|---|---|---|---|
| |
Failure
(%) |
No failure
(%) |
OR (95 % CI) |
value |
| Male sex | (57.1) | (42.9) | 0.80 (0.5–1.4) | 0.438 |
| Charlson Comorbidity Index 3 | (78.3) | (21.7) | 3.39 (1.2–9.5) | 0.015 |
| CRP 150 mg L−1 | (69.6) | (30.4) | 2.29 (1.1–4.6) | 0.021 |
| Bacteraemia | (70.6) | (29.4) | 2.13 (0.7–6.3) | 0.161 |
| Fracture indication | (51.7) | (48.3) | 0.88 (0.5–1.6) | 0.669 |
| Revision prosthesis | (71.8) | (28.2) | 3.02 (1.6–5.5) | |
| Cemented prosthesis | (52.8) | (47.2) | 0.67 (0.3–1.3) | 0.243 |
| Hip PJI | (57.3) | (42.7) | 1.34 (0.8–2.3) | 0.277 |
| Gram-negative infection | (66.7) | (33.3) | 1.90 (0.9–3.9) | 0.068 |
| Polymicrobial infection |
(68.0) |
(32.0) |
1.90 (0.8–4.7) |
0.137 |
| Continuous variables | ||||
| |
Failure median (IQR) |
No failure median (IQR) |
value |
|
| Age (years) | 70 (63–79) | 70 (65–77) | 0.545 | |
| Charlson Comorbidity Index | 1 (0–1) | 1 (0–1) | 0.098 | |
| Haemoglobin (g dL−1) | 10.5 (9.4–11.6) | 10.6 (9.5–11.6) | 0.457 | |
| Leucocyte count (cell mm−3) | 8250 (6420–11 570) | 8780 (6503–12 615) | 0.920 | |
| CRP (mg L−1) | 77.5 (27–187) | 61.5 (23–133) | 0.023 | |
| Time from index arthroplasty to DAIR (days) | 43 (27–208) | 31 (20–39) | ||
Denominators vary due to missing data and are shown where applicable. CRP: C-reactive protein; DAIR: debridement, antibiotics, and implant retention.